These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22526517)

  • 61. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole.
    Bicanic T; Meintjes G; Wood R; Hayes M; Rebe K; Bekker LG; Harrison T
    Clin Infect Dis; 2007 Jul; 45(1):76-80. PubMed ID: 17554704
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis.
    Wirth F; de Azevedo MI; Pilla C; Aquino VR; Neto GW; Goldani LZ
    Med Mycol; 2018 Apr; 56(3):257-262. PubMed ID: 28992308
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients.
    Manosuthi W; Chetchotisakd P; Nolen TL; Wallace D; Sungkanuparph S; Anekthananon T; Supparatpinyo K; Pappas PG; Larsen RA; Filler SG; Andes D;
    HIV Med; 2010 Apr; 11(4):276-81. PubMed ID: 20002501
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitis.
    Diamond DM; Bauer M; Daniel BE; Leal MA; Johnson D; Williams BK; Thomas AM; Ding JC; Najvar L; Graybill JR; Larsen RA
    Antimicrob Agents Chemother; 1998 Mar; 42(3):528-33. PubMed ID: 9517927
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A retrospective study of AIDS-associated cryptomeningitis.
    Sachdeva RK; Randev S; Sharma A; Wanchu A; Chakrabarti A; Singh S; Varma S
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1220-6. PubMed ID: 22369456
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of liposomal amphotericin B alone and in combination with flucytosine in the treatment of non-HIV Cryptococcal meningitis: A nationwide observational study.
    Takazono T; Hidaka Y; Morimoto S; Tashiro M; Ashizawa N; Hirayama T; Takeda K; Iwanaga N; Hosogaya N; Yamamoto K; Fushimi K; Yanagihara K; Mukae H; Izumikawa K
    Mycoses; 2022 Sep; 65(9):897-902. PubMed ID: 35802067
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis.
    Larsen RA; Bauer M; Thomas AM; Graybill JR
    Antimicrob Agents Chemother; 2004 Mar; 48(3):985-91. PubMed ID: 14982793
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [A clinical study of 26 cases of cryptococcal meningitis].
    Liu Z; Wang A; Li T; Qin S; Sheng R
    Zhonghua Nei Ke Za Zhi; 2002 Aug; 41(8):541-3. PubMed ID: 12421503
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Evaluation of low-dose amphotericin B and flucytosine in the treatment of cryptococcal meningitis].
    Xu B; Wu JQ; Ou XT; Xie Y; Huang YX; Jiang WM; Jin JL; Zhu LP; Weng XH
    Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(6):379-81. PubMed ID: 20367933
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Liposomal amphotericin B (Fungisome) for the treatment of cryptococcal meningitis in HIV/AIDS patients in India: a multicentric, randomized controlled trial.
    Jadhav MP; Bamba A; Shinde VM; Gogtay N; Kshirsagar NA; Bichile LS; Mathai D; Sharma A; Varma S; Digumarathi R
    J Postgrad Med; 2010; 56(2):71-5. PubMed ID: 20622383
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An open label randomized controlled trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis.
    Ngan NTT; Thanh Hoang Le N; Vi Vi NN; Van NTT; Mai NTH; Van Anh D; Trieu PH; Lan NPH; Phu NH; Chau NVV; Lalloo DG; Hope W; Beardsley J; White NJ; Geskus R; Thwaites GE; Krysan D; Tai LTH; Kestelyn E; Binh TQ; Hung LQ; Tung NLN; Day JN
    Elife; 2021 Sep; 10():. PubMed ID: 34581270
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial.
    Rhein J; Huppler Hullsiek K; Tugume L; Nuwagira E; Mpoza E; Evans EE; Kiggundu R; Pastick KA; Ssebambulidde K; Akampurira A; Williams DA; Bangdiwala AS; Abassi M; Musubire AK; Nicol MR; Muzoora C; Meya DB; Boulware DR;
    Lancet Infect Dis; 2019 Aug; 19(8):843-851. PubMed ID: 31345462
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy of induction regimens for cryptococcal meningitis in HIV-infected adults: a systematic review and network meta-analysis.
    Chen CH; Li H; Chen HM; Chen YM; Chang YJ; Lin PY; Hsu CW; Tseng PT; Lin KH; Tu YK
    Sci Rep; 2021 Apr; 11(1):8565. PubMed ID: 33883566
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of one week with two week regimens of amphotericin B both followed by fluconazole in the treatment of cryptococcal meningitis among AIDS patients.
    Tansuphaswadikul S; Maek-a-Nantawat W; Phonrat B; Boonpokbn L; Mctm AG; Pitisuttithum P
    J Med Assoc Thai; 2006 Oct; 89(10):1677-85. PubMed ID: 17128844
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure.
    Li M; Liu J; Deng X; Gan Q; Wang Y; Xu X; Jiang Y; Peng F
    BMC Infect Dis; 2020 Nov; 20(1):844. PubMed ID: 33198666
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.
    Lofgren S; Abassi M; Rhein J; Boulware DR
    Expert Rev Anti Infect Ther; 2017 Apr; 15(4):331-340. PubMed ID: 28111998
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cryptococcal meningitis in patients with the acquired immunodeficiency syndrome.
    Zeind CS; Cleveland KO; Menon M; Brown JR; Solomon DK
    Pharmacotherapy; 1996; 16(4):547-61. PubMed ID: 8840361
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial.
    Day J; Imran D; Ganiem AR; Tjahjani N; Wahyuningsih R; Adawiyah R; Dance D; Mayxay M; Newton P; Phetsouvanh R; Rattanavong S; Chan AK; Heyderman R; van Oosterhout JJ; Chierakul W; Day N; Kamali A; Kibengo F; Ruzagira E; Gray A; Lalloo DG; Beardsley J; Binh TQ; Chau TT; Chau NV; Cuc NT; Farrar J; Hien TT; Van Kinh N; Merson L; Phuong L; Tho LT; Thuy PT; Thwaites G; Wertheim H; Wolbers M
    Trials; 2014 Nov; 15():441. PubMed ID: 25391338
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar.
    Warrell CE; Macrae C; McLean ARD; Wilkins E; Ashley EA; Smithuis F; Tun NN
    BMC Infect Dis; 2021 Apr; 21(1):375. PubMed ID: 33882845
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HIV-Associated Cryptococcal Meningitis Patients Treated with Amphotericin B Deoxycholate Plus Flucytosine under Routine Care Conditions in a Referral Center in São Paulo, Brazil.
    Vidal JE; de Albuquerque Moraes C; de Siqueira REB; Miranda NFB; Marcusso R; Boulware DR; de Oliveira ACP
    Mycopathologia; 2021 Mar; 186(1):93-102. PubMed ID: 33258083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.